Next Generation Of Fluorine-Containing Pharmaceuticals, Compounds Currently In Phase II–III Clinical Trials Of Major Pharmaceutical Companies: New Structural Trends And Therapeutic Areas

·2016·DOI

Role in the Field

Abstract

Citations

2,280

Year

2016

PageRank

3.2 / 10

Relative influence (log-scaled)

Next Generation Of Fluorine-Containing Pharmaceuticals, Compounds Currently In Phase II–III Clinical Trials Of Major Pharmaceutical Companies: New Structural Trends And Therapeutic Areas | Manumap